Pharmafile Logo
Pharmafocus logo
Advanced Search

SERB acquires BTG to expand its treatment portfolio for unmet medical needs

March 2, 2021
Manufacturing and Production BTG, SERB, specialty pharmaceuticals

SERB Specialty Pharmaceuticals has purchased BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops treatments with critical conditions, for …

News

Single Pfizer or AstraZeneca vaccine dose drastically reduces COVID-19 hospitalisations in over-80s

March 2, 2021
Manufacturing and Production AstraZeneca, COVID-19, COVID-19 vaccine, Pfizer, Vaccine

A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …

News
sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …

Appointment

Cancer Research UK joins forces with Teon to develop new cancer drug

March 2, 2021
Manufacturing and Production Cancer, Cancer Research UK, Teon

Cancer Research UK and Teon Therapeutics have entered a collaboration agreement to progress the early phase clinical development of Teon’s new cancer drug. The partnership …

News

CN Bio receives UK government grant to develop single and multi-organ models for COVID-19 research

March 2, 2021
Manufacturing and Production CN Bio, COVID-19

CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate …

News

Iktos and Pfizer collaborate on AI drug design

March 2, 2021
Manufacturing and Production AI, Iktos, Pfizer

Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …

News
Merck building

Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments

March 1, 2021
Sales and Marketing Debiopharm, Merck, cancer treatment, head and neck cancer, xevinapant

German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation of …

News

Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal

March 1, 2021
Sales and Marketing Cancer, Kazia, Oasmia

Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia Therapeutics’ ovarian cancer …

News
Evotec building

Evotec and Chinook to partner on new kidney disease treatments

March 1, 2021
Sales and Marketing CKD, Chinook, Evotec, chronic kidney disease, kidney disease

Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases …

News

FDA approves Johnson & Johnson’s COVID-19 vaccine for emergency use

March 1, 2021
Sales and Marketing COVID-19, Janssen, Johnson & Johnson, vaccines

The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in …

News

Ipsen receives CHMP recommendation for Cabometyx in combination with Opdivo

March 1, 2021
Sales and Marketing Cancer, EMA, ipsen

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for Ipsen’s Cabometyx (cabozantinib) in combination with …

News
cov

MAPs during a global pandemic

February 26, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …

Feature
top 10

Pharmafile.com’s top 10 news stories of the week

February 26, 2021
Medical Communications news, pharma news, pharmaceuticals, pharmafile, top news stories

COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …

News
GSK building

GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s

February 26, 2021
Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab

GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …

News

How COVID-19 has changed pharmacovigilance

February 26, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …

Feature

NICE recommends Novartis’ ribociclib in combination with fulvestrant for breast cancer

February 26, 2021
Medical Communications Cancer, NICE, Novartis

NICE has recommended Novartis’ Kisqali (ribociclib) in combination with fulvestrant for women with prior endocrine therapy. It will be made …

News
merckincweb

MSD acquires Pandion Therapeutics in $1.85bn deal

February 26, 2021
Medical Communications MSD, Pandion

MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion …

News
takeda_usa_pharmaceuticals_u

Takeda sells four diabetes products to Teijin Pharma for $1.25m

February 26, 2021
Medical Communications Takeda

Takeda has entered into an agreement to transfer the assets, marketing rights, and, eventually, marketing authorisation associated with a portfolio …

News
a vaccination is given

Ghana is first African country to receive COVID-19 vaccines from COVAX

February 25, 2021

The COVAX Facility have delivered their first batch of COVID-19 vaccines to Africa, with 600,000 doses of the Oxford-AstraZeneca vaccine …

News

Xencor and UCLA TDG partner to develop therapeutic antibodies

February 25, 2021
Xencor, ucla

Xencor and UCLA Technology Development Group (UCLA TDG) have announced an agreement to develop novel therapeutic antibodies, pairing novel targets …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026